Clinical trial
Evaluation of a Healthcare Transition Protocol for Patients With Congenital Adrenal Hyperplasia
NCT07611786 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Healthcare Transition Protocol for Patients With Congenital Adrenal Hyperplasia
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2027
- Completion date
- December 31, 2029
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital adrenal hyperplasia